Showing 1 - 3 results of 3 for search 'Emmanuel Krupka', query time: 0.02s Refine Results
  1. 1
    A first‐in‐human, single and multiple dose study of lunsekimig, a novel anti‐TSLP/anti‐IL‐13 NANOBODY® compound, in healthy volunteers

    A first‐in‐human, single and multiple dose study of lunsekimig, a novel anti‐TSLP/anti‐IL‐13 NANOBODY® compound, in healthy volunteers by Annemie Deiteren, Lieselot Bontinck, Griet Conickx, Marie Vigan, Nele Dervaux, Matthieu Gassiot, Selcuk Bas, Benjamin Suratt, Heribert Staudinger, Emmanuel Krupka

    Published 2024
    Connect to this object online.
    Book
    Save to List
    Saved in:
  2. 2
    A phase I trial assessing the safety, pharmacokinetics, cerebrospinal fluid penetrance, and food effect of BTK inhibitor tolebrutinib in healthy volunteers

    A phase I trial assessing the safety, pharmacokinetics, cerebrospinal fluid penetrance, and food effect of BTK inhibitor tolebrutinib in healthy volunteers by Marie‐José Cabanis, Olivier Nicolas, Olivier Vitse, Christelle Jan, Priscilla Brun, Patrick Soubayrol, William B. Smith, Timothy J. Turner, Emmanuel Krupka

    Published 2024
    Connect to this object online.
    Book
    Save to List
    Saved in:
  3. 3
    Safety, pharmacokinetics, and target engagement of a brain penetrant RIPK1 inhibitor, SAR443820 (DNL788), in healthy adult participants

    Safety, pharmacokinetics, and target engagement of a brain penetrant RIPK1 inhibitor, SAR443820 (DNL788), in healthy adult participants by Agnes Hincelin‐Mery, Xavier Nicolas, Cathy Cantalloube, Robert Pomponio, Pascale Lewanczyk, Myriam Benamor, Dimitry Ofengeim, Emmanuel Krupka, Jennifer Hsiao‐Nakamoto, Amy Eastenson, Nazem Atassi

    Published 2024
    Connect to this object online.
    Book
    Save to List
    Saved in:

Search Tools: